- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Extension to Promissory Notes | 223 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it has extended the maturity date of its outstanding... ► Artikel lesen | |
| 29.11. | Rapid Dose Therapeutics Corp: Rapid Dose to extend note maturity date | 2 | Stockwatch | ||
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 29.11. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Extension to Promissory Notes | 417 | Newsfile | Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding... ► Artikel lesen | |
| 18.11. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Extends NicStrip Deal with Nicotine Partner as Health Canada Reviews Product | 308 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 18, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the... ► Artikel lesen | |
| 21.10. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben Monate. | 345 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben... ► Artikel lesen | |
| 21.10. | Rapid Dose Therapeutics Corp: Rapid Dose extends precommercialization nicotine deal | 3 | Stockwatch | ||
| 20.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner | 372 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative drug delivery solutions... ► Artikel lesen | |
| 03.10. | Rapid Dose Therapeutics Corp: Rapid Dose pays debt interest with 592,533 shares | 2 | Stockwatch | ||
| 02.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 413 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 04.08. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Submits QuickStrip Nicotine Product for Health Canada Approval | 454 | Newsfile | Burlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company focused on innovative drug delivery technologies... ► Artikel lesen | |
| 29.07. | Rapid Dose Therapeutics Corp: Rapid Dose, Eco work on harm reduction pilot project | 2 | Stockwatch | ||
| 29.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip to Combat Opiate Addiction Crisis | 221 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new... ► Artikel lesen | |
| 22.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine | 611 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 04.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares as fee payments to directors | 1 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics issues shares for interest | 2 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 538 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 650 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 02.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study | 340 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 02.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors | 393 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has... ► Artikel lesen | |
| 28.05. | PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller | 361 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics Inc.: Partnerschaft mit... ► Artikel lesen |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 82,00 | -0,61 % | JEFFERIES stuft Biontech auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Biontech auf "Buy" mit einem Kursziel von 151 US-Dollar belassen. Die 12-Monats-Überlebensrate von Patienten mit einem... ► Artikel lesen | |
| CORE ONE LABS | 0,079 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,410 | -0,97 % | BioNxt treibt "Melt in Your Mouth"-Cladribin-Formulierung voran, um die Behandlung von MS-Patienten mit Dysphagie zu verbessern | VANCOUVER, BC / ACCESS Newswire / 9. Dezember 2025 / BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT) meldet Fortschritte bei der Entwicklung einer neuartigen... ► Artikel lesen | |
| CLINUVEL | 7,245 | +2,19 % | Clinuvel Pharmaceuticals Limited: CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies | EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery... ► Artikel lesen | |
| VIDAC PHARMA | 0,540 | -2,17 % | XFRA NEW INSTRUMENTS AVAILABLE ON 04.12.2025 | The following instruments on XETRA do have their first trading 04.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.12.2025
Aktien
1 JP3172060000 Aucnet Inc.
2 JP3778270003... ► Artikel lesen | |
| ATAI BECKLEY | 3,738 | -1,35 % | Psychedelika bewegen sich über das Versprechen hinaus - Atai und Bioxyne im Rampenlicht | ||
| SOL GLOBAL INVESTMENTS | 0,012 | +6,42 % | SOL Global Investments Corp.: SOL Global Announces Share Consolidation | Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL" or the "Company") announces that a majority vote by its Board of Directors... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,312 | -4,29 % | MustGrow Biologics Corp.: MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante | Mustard-derived organic TerraSanteTM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;Large scale field trial showed 2 ton per acre yield increase with larger... ► Artikel lesen | |
| TVARDI THERAPEUTICS | 3,600 | -2,23 % | Tvardi Therapeutics, Inc.: Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London | Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,006 | 0,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study | TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| CYBIN | 5,150 | +3,00 % | Cybin Inc.: Cybin to Participate in the Jefferies Global Healthcare Conference in London | Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 1,940 | +4,86 % | Artelo's FABP5 inhibitor shows promise for anxiety and depression | ||
| LOBE SCIENCES | 0,022 | 0,00 % | Lobe Sciences Ltd.: Lobe Sciences Completes Debt Settlement to Improve Balance Sheet | VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 68,07 | +1,99 % | Structure Therapeutics Inc.: Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants | SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 89,78 | +3,34 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis | KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation... ► Artikel lesen |
RAPID DOSE THERAPEUTICS CORP gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.